Kidney treatment company DaVita (DVA) on Monday afternoon reported first-quarter 2025 financial results. A summary of its key numbers is below. Read the company’s earnings press release here.
| Table | Q1 2025 | Estimate* | Q1 2024 |
| Revenue | $3.22B | $3.21B | $3.07B |
| Net Income** | $163M | $139M | $205M |
| EPS*** | $2.00 | $1.68 | $2.26 |
* Estimates reflect the pre-earnings means from Visible Alpha.
** Net income reflects the company’s reported adjusted number.
*** Earnings per share reflects the company’s reported adjusted and diluted number.
:max_bytes(150000):strip_icc()/GettyImages-1421088347-2feb0ea4776a4166a6fab47e74aa2f5f.jpg?w=1200&resize=1200,0&ssl=1&description=DaVita+First-Quarter+2025+Financial+Results%3A+Just+the+Numbers){kind=link}